Maryland Man Pleads Guilty in Drug Sale Causing Teen's Death

GREENBELT, Md. — Kelvin Reyes, a 27-year-old resident of Gaithersburg, Maryland, entered a guilty plea on May 4, 2026, in the U.S. District Court for the District of Maryland to charges of distributing controlled substances that caused the death of a 15-year-old girl, per a U.S. Department of Justice press release.

The plea directly impacts Reyes and the victim's family, with the incident involving a single transaction where the girl contacted Reyes via a social media platform to purchase narcotics. The bundle specifies one fatality—a 15-year-old female—and one defendant, without detailing broader case involvement or additional victims.

Federal drug distribution cases like this typically affect local communities by targeting suppliers linked to overdoses, though the release does not quantify wider enforcement statistics or community reach. Standard knowledge of U.S. drug laws indicates that such offenses under 21 U.S.C. § 841, which prohibits distribution of controlled substances, can involve penalties scaled by substance quantity and harm caused, but the bundle provides no specifics on the narcotics type or amount.

Prior to the plea, Reyes faced initial charges following an investigation into the girl's death, with the case progressing to federal court. The new state establishes his guilt, shifting the proceedings to sentencing, which the bundle does not date but standard federal procedure schedules within months after a plea, often guided by presentence reports.

This change eliminates a trial, streamlining the judicial process under rules set by the U.S. Sentencing Commission.

The guilty plea triggers mandatory minimum sentences under federal law for distributions resulting in death, requiring at least 20 years in prison if the substance qualifies, per 21 U.S.C. § 841(b)(1)(C), with judges now required to consider aggravating factors like the victim's age during sentencing.

Prosecutors must file sentencing recommendations, potentially by June 2026 based on typical timelines, while the defense can seek reductions for cooperation, activating Bureau of Prisons placement processes post-sentencing. This also initiates any restitution orders to the victim's family, as federal courts often mandate compensation for losses in fatal cases.

The plea follows a pattern of federal actions against social media-facilitated drug sales, with the U.S. Attorney's Office for the District of Maryland handling similar cases in recent years, including indictments tied to fentanyl distributions since 2024.

Congress passed the SUPPORT for Patients and Communities Act in 2018, which expanded resources for such prosecutions, though the bundle does not link this case explicitly to that legislation.